Crispr Therapeutics shares tumble after significant earnings miss
Jeffrey Kutz, Vice President and Chief Accounting Officer at Quaker Chemical Corp (NYSE:KWR), recently sold a portion of his holdings in the company. According to a Form 4 filing with the Securities and Exchange Commission, Kutz sold 251 shares of common stock on February 28, 2025, at a price of $140 per share, totaling $35,140. Following this transaction, Kutz retains ownership of 374 shares directly. The sale comes as the stock trades near its 52-week low, with shares down 29% over the past year. According to InvestingPro analysis, the stock currently appears undervalued based on its Fair Value model.
The sale was executed as part of regular trading activity and was disclosed in compliance with regulatory requirements. Quaker Chemical, headquartered in Conshohocken, Pennsylvania, specializes in products related to petroleum and coal. The company has maintained dividend payments for 53 consecutive years and management has been actively buying back shares. For deeper insights into KWR’s financials and growth prospects, access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Quaker Chemical Corporation reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of $1.33, which fell short of the analysts’ forecast of $1.62. Despite this, the company’s revenue exceeded expectations, reaching $444.09 million compared to the anticipated $441.87 million. The company achieved a full-year adjusted EBITDA of $311 million, demonstrating robust financial performance. Quaker Chemical’s strategic investments and acquisitions, such as the recent purchase of Chemical Solutions and Innovations in South Africa, are expected to bolster future growth. Analysts have noted that the company anticipates revenue, adjusted EBITDA, and earnings growth in 2025, with market growth projected at 1-2%. However, foreign exchange is expected to pose a low single-digit percentage headwind. CEO Joe Bergquist emphasized the company’s focus on commercial and operational improvements and expects to grow revenue, EBITDA, and earnings in the upcoming year. Despite a year-over-year decline in net sales by 5%, the company continues to pursue strategic initiatives in new markets, such as battery electric vehicles, to maintain competitiveness.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.